Steven H J Hageman
Overview
Explore the profile of Steven H J Hageman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Bijkerk S, Visseren F, van der Meer M, de Borst G, Ruigrok Y, Jernberg T, et al.
Eur J Prev Cardiol
. 2025 Feb;
PMID: 39951499
Aim: This study aimed to evaluate whether lower socioeconomic status (SES) is related to a higher risk of recurrent cardiovascular disease (CVD) events and reduced CVD-free life expectancy in a...
3.
Arsyad D, Qalby N, Qanitha A, Mappangara I, Milayanti W, Wahiduddin , et al.
J Eval Clin Pract
. 2025 Jan;
31(1):e14311.
PMID: 39803729
Rationale: Established coronary artery disease (CAD) patients are at increased risk for recurrence of cardiovascular events and mortality due to non-attainment of recommended risk factor control targets. Objective: We aimed...
4.
Poorthuis M, Hageman S, Fiolet A, Kappelle L, Bots M, Steg P, et al.
Stroke
. 2024 Sep;
55(11):2632-2640.
PMID: 39319460
Background: Risk models to identify patients at high risk of asymptomatic carotid artery stenosis (ACAS) can help in selecting patients for screening, but long-term outcomes in these patients are unknown....
5.
van Apeldoorn J, Hageman S, Harskamp R, Agyemang C, van den Born B, van Dalen J, et al.
Int J Cardiol
. 2024 Sep;
417:132525.
PMID: 39244095
Background: Current prediction models for mainland Europe do not include ethnicity, despite ethnic disparities in cardiovascular disease (CVD) risk. SCORE2 performance was evaluated across the largest ethnic groups in the...
6.
Hageman S, Huang Z, Lee H, Kaptoge S, Dorresteijn J, Pennells L, et al.
Eur Heart J
. 2024 Sep;
46(8):702-715.
PMID: 39217477
Background And Aims: To improve upon the estimation of 10-year cardiovascular disease (CVD) event risk for individuals without prior CVD or diabetes mellitus in the Asia-Pacific region by systematic recalibration...
7.
Dorresteijn J, Hageman S, Visseren F, Bhatt D
JACC Adv
. 2024 Aug;
3(9):101089.
PMID: 39165835
No abstract available.
8.
Hageman S, Post R, Visseren F, McEvoy J, Jukema J, Smulders Y, et al.
J Clin Epidemiol
. 2024 Jul;
173:111464.
PMID: 39019349
Background: Cardiovascular disease (CVD) risk scores provide point estimates of individual risk without uncertainty quantification. The objective of the current study was to demonstrate the feasibility and clinical utility of...
9.
Hageman S, Kaptoge S, de Vries T, Lu W, Kist J, van Os H, et al.
Eur J Prev Cardiol
. 2024 May;
31(14):1690-1699.
PMID: 38752762
Aims: The 2021 European Society of Cardiology prevention guidelines recommend the use of (lifetime) risk prediction models to aid decisions regarding initiation of prevention. We aimed to update and systematically...
10.
Helmink M, Peters S, Westerink J, Harris K, Tillmann T, Woodward M, et al.
Eur J Prev Cardiol
. 2024 Apr;
31(14):1671-1678.
PMID: 38584392
Aims: Identifying patients with established cardiovascular disease (CVD) who are at high risk of type 2 diabetes (T2D) may allow for early interventions, reducing the development of T2D and associated...